
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Healthcare
Medical Equipment
62 Cr
Low Risk
24.7
45.5
0.8
2.6
81.99
36.00
Sales CAGR
1Y
23.56%
3Y
1.69%
5Y
—
10Y
—
Profit CAGR
1Y
27.00%
3Y
31.53%
5Y
—
10Y
—
ROE
TTM
13.37%
3Y
18.14%
5Y
23.12%
10Y
—
ROCE
TTM
17.10%
3Y
23.97%
5Y
28.61%
10Y
—
Amkay Products Ltd (AMKAY) is currently trading at 75.60 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Amkay Products Ltd is a manufacturer and marketer of medical devices and healthcare products, serving centers, hospitals, clinics, and nursing homes in India. The company has expanded its product line significantly from its initial offering, now including items like face masks, alcohol swabs, digital thermometers, and more. Founded in 2007, Amkay Products has grown its manufacturing capacity with units in Vasai and Thane, indicating a strategic expansion. The company is preparing for an Initial Public Offering to issue 22,92,000 equity shares, aiming to strengthen its financial position and support growth. Amkay has developed branding and marketing capabilities, facilitating the promotion of products like diapers and plastic gloves in its broader offerings.
Over the past 52 weeks, Amkay Products Ltd has traded between a low of ₹36.00 and a high of ₹81.99. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Amkay Products Ltd has a market capitalization of approximately 62.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Amkay Products Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.74 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
You can buy shares of Amkay Products Ltd (AMKAY) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.
Based on its market capitalization of 62.32 Cr, Amkay Products Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Amkay Products Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Amkay Products Ltd is 24.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Amkay Products Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.
Key risks associated with Amkay Products Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.
Bearish
2
Neutral
9
Bullish
3
Bearish
4
Neutral
13
Bullish
29
Bearish
2
Neutral
4
Bullish
26
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Performance
UNDER PERFORMER
Valuation
UNDERVALUED
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Bullish
Risk
MODERATE RISK
Market Cap
₹ 62 Cr
P/E
24.74